Hypertensive emergencies in Asia: A brief review

Praew Kotruchin; Thanat Tangpaisarn; Thapanawong Mitsungnern; Apichard Sukonthasarn; Satoshi Hoshide; Yuda Turana; Saulat Siddique; Peera Buranakitjaroen; Minh Van Huynh; Yook Chin Chia; Sungha Park; Chen Huan Chen; Jennifer Nailes; Jam Chin Tay; Ji Guang Wang; Kazuomi Kario

doi:10.1111/jch.14547

Hypertensive emergencies in Asia: A brief review

Praew Kotruchin, Thanat Tangpaisarn, Thapanawong Mitsungnern, Apichard Sukonthasarn, Satoshi Hoshide, Yuda Turana, Saulat Siddique, Peera Buranakitjaroen, Minh Van Huynh, Yook Chin Chia, Sungha Park, Chen Huan Chen, Jennifer Nailes, Jam Chin Tay, Ji Guang Wang, Kazuomi Kario

Department of Internal Medicine

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Abstract

Hypertensive emergency is one of the most challenging conditions to treat in the emergency department (ED). From previous studies, about 1%–3% of hypertensive individuals experienced hypertensive emergencies. Its prevalence varied by country and region throughout Asia. Asian populations have more different biological and cultural backgrounds than Caucasians and even within Asian countries. However, there is a scarcity of research on clinical features, treatment, and outcomes in multinational Asian populations. The authors aimed to review the current evidence about epidemiology, clinical characteristics and outcomes, and practice guidelines in Asia. Five observational studies and nine clinical practice guidelines across Asia were reviewed. The prevalence of hypertensive emergencies ranged from.1% to 1.5%. Stroke was the most common target organ involvement in Asians who presented with hypertensive emergencies. Although most hypertensive emergency patients required hospitalization, the mortality rate was low. Given the current lack of data among Asian countries, a multinational data repository and Asian guidelines on hypertensive emergency management are mandatory.

Original language	English
Pages (from-to)	1226-1235
Number of pages	10
Journal	Journal of Clinical Hypertension
Volume	24
Issue number	9
DOIs	https://doi.org/10.1111/jch.14547
Publication status	Published - 2022 Sept

Bibliographical note

Funding Information:
The authors would like to thank the Department of Emergency Medicine, Faculty of Medicine, Khon Kaen University for their support. The authors would also like to give our sincere gratitude to the HOPE ASIA network for this research opportunity and for sustaining hypertension-related initiatives in the region.

Funding Information:
S Siddique has received honoraria from Bayer, Getz Pharma, Novartis, Pfizer, ICI, and Servier; and travel, accommodation, and conference registration support from Hilton Pharma, Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma, and ICI. YC Chia has received unrestricted educational grants from Viatris and Omron and from Medtronic for activities of the Malaysian Society for World Action on Salt, Sugar, and Health (MyWASSH). YC Chia also has received speaker honoraria from Medtronic, Astra‐Zeneca, Omron, and Xepa‐Sol. S Park received lecture fees from Pfizer, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, and Daewon. S Park also received a research grant from Daiichi Sankyo. All other authors had no competing interests.

Publisher Copyright:
© 2022 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.

All Science Journal Classification (ASJC) codes

Internal Medicine
Endocrinology, Diabetes and Metabolism
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jch.14547

Cite this

Kotruchin, P., Tangpaisarn, T., Mitsungnern, T., Sukonthasarn, A., Hoshide, S., Turana, Y., Siddique, S., Buranakitjaroen, P., Van Huynh, M., Chia, Y. C., Park, S., Chen, C. H., Nailes, J., Tay, J. C., Wang, J. G., & Kario, K. (2022). Hypertensive emergencies in Asia: A brief review. Journal of Clinical Hypertension, 24(9), 1226-1235. https://doi.org/10.1111/jch.14547

@article{6ee9d54331d44fa29f4dd56931d95418,

title = "Hypertensive emergencies in Asia: A brief review",

abstract = "Hypertensive emergency is one of the most challenging conditions to treat in the emergency department (ED). From previous studies, about 1%–3% of hypertensive individuals experienced hypertensive emergencies. Its prevalence varied by country and region throughout Asia. Asian populations have more different biological and cultural backgrounds than Caucasians and even within Asian countries. However, there is a scarcity of research on clinical features, treatment, and outcomes in multinational Asian populations. The authors aimed to review the current evidence about epidemiology, clinical characteristics and outcomes, and practice guidelines in Asia. Five observational studies and nine clinical practice guidelines across Asia were reviewed. The prevalence of hypertensive emergencies ranged from.1% to 1.5%. Stroke was the most common target organ involvement in Asians who presented with hypertensive emergencies. Although most hypertensive emergency patients required hospitalization, the mortality rate was low. Given the current lack of data among Asian countries, a multinational data repository and Asian guidelines on hypertensive emergency management are mandatory.",

author = "Praew Kotruchin and Thanat Tangpaisarn and Thapanawong Mitsungnern and Apichard Sukonthasarn and Satoshi Hoshide and Yuda Turana and Saulat Siddique and Peera Buranakitjaroen and {Van Huynh}, Minh and Chia, {Yook Chin} and Sungha Park and Chen, {Chen Huan} and Jennifer Nailes and Tay, {Jam Chin} and Wang, {Ji Guang} and Kazuomi Kario",

note = "Funding Information: The authors would like to thank the Department of Emergency Medicine, Faculty of Medicine, Khon Kaen University for their support. The authors would also like to give our sincere gratitude to the HOPE ASIA network for this research opportunity and for sustaining hypertension-related initiatives in the region. Funding Information: S Siddique has received honoraria from Bayer, Getz Pharma, Novartis, Pfizer, ICI, and Servier; and travel, accommodation, and conference registration support from Hilton Pharma, Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma, and ICI. YC Chia has received unrestricted educational grants from Viatris and Omron and from Medtronic for activities of the Malaysian Society for World Action on Salt, Sugar, and Health (MyWASSH). YC Chia also has received speaker honoraria from Medtronic, Astra‐Zeneca, Omron, and Xepa‐Sol. S Park received lecture fees from Pfizer, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, and Daewon. S Park also received a research grant from Daiichi Sankyo. All other authors had no competing interests. Publisher Copyright: {\textcopyright} 2022 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.",

year = "2022",

month = sep,

doi = "10.1111/jch.14547",

language = "English",

volume = "24",

pages = "1226--1235",

journal = "Journal of Clinical Hypertension",

issn = "1524-6175",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Hypertensive emergencies in Asia

T2 - A brief review

AU - Kotruchin, Praew

AU - Tangpaisarn, Thanat

AU - Mitsungnern, Thapanawong

AU - Sukonthasarn, Apichard

AU - Hoshide, Satoshi

AU - Turana, Yuda

AU - Siddique, Saulat

AU - Buranakitjaroen, Peera

AU - Van Huynh, Minh

AU - Chia, Yook Chin

AU - Park, Sungha

AU - Chen, Chen Huan

AU - Nailes, Jennifer

AU - Tay, Jam Chin

AU - Wang, Ji Guang

AU - Kario, Kazuomi

N1 - Funding Information: The authors would like to thank the Department of Emergency Medicine, Faculty of Medicine, Khon Kaen University for their support. The authors would also like to give our sincere gratitude to the HOPE ASIA network for this research opportunity and for sustaining hypertension-related initiatives in the region. Funding Information: S Siddique has received honoraria from Bayer, Getz Pharma, Novartis, Pfizer, ICI, and Servier; and travel, accommodation, and conference registration support from Hilton Pharma, Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma, and ICI. YC Chia has received unrestricted educational grants from Viatris and Omron and from Medtronic for activities of the Malaysian Society for World Action on Salt, Sugar, and Health (MyWASSH). YC Chia also has received speaker honoraria from Medtronic, Astra‐Zeneca, Omron, and Xepa‐Sol. S Park received lecture fees from Pfizer, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, and Daewon. S Park also received a research grant from Daiichi Sankyo. All other authors had no competing interests. Publisher Copyright: © 2022 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.

PY - 2022/9

Y1 - 2022/9

N2 - Hypertensive emergency is one of the most challenging conditions to treat in the emergency department (ED). From previous studies, about 1%–3% of hypertensive individuals experienced hypertensive emergencies. Its prevalence varied by country and region throughout Asia. Asian populations have more different biological and cultural backgrounds than Caucasians and even within Asian countries. However, there is a scarcity of research on clinical features, treatment, and outcomes in multinational Asian populations. The authors aimed to review the current evidence about epidemiology, clinical characteristics and outcomes, and practice guidelines in Asia. Five observational studies and nine clinical practice guidelines across Asia were reviewed. The prevalence of hypertensive emergencies ranged from.1% to 1.5%. Stroke was the most common target organ involvement in Asians who presented with hypertensive emergencies. Although most hypertensive emergency patients required hospitalization, the mortality rate was low. Given the current lack of data among Asian countries, a multinational data repository and Asian guidelines on hypertensive emergency management are mandatory.

AB - Hypertensive emergency is one of the most challenging conditions to treat in the emergency department (ED). From previous studies, about 1%–3% of hypertensive individuals experienced hypertensive emergencies. Its prevalence varied by country and region throughout Asia. Asian populations have more different biological and cultural backgrounds than Caucasians and even within Asian countries. However, there is a scarcity of research on clinical features, treatment, and outcomes in multinational Asian populations. The authors aimed to review the current evidence about epidemiology, clinical characteristics and outcomes, and practice guidelines in Asia. Five observational studies and nine clinical practice guidelines across Asia were reviewed. The prevalence of hypertensive emergencies ranged from.1% to 1.5%. Stroke was the most common target organ involvement in Asians who presented with hypertensive emergencies. Although most hypertensive emergency patients required hospitalization, the mortality rate was low. Given the current lack of data among Asian countries, a multinational data repository and Asian guidelines on hypertensive emergency management are mandatory.

UR - http://www.scopus.com/inward/record.url?scp=85139229573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139229573&partnerID=8YFLogxK

U2 - 10.1111/jch.14547

DO - 10.1111/jch.14547

M3 - Review article

C2 - 36196470

AN - SCOPUS:85139229573

SN - 1524-6175

VL - 24

SP - 1226

EP - 1235

JO - Journal of Clinical Hypertension

JF - Journal of Clinical Hypertension

IS - 9

ER -

Hypertensive emergencies in Asia: A brief review

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this